1. 8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group. (September 2015) Authors: Dearnaley, D.; Syndikus, I.; Mossop, H.; Birtle, A.; Bloomfield, D.; Cruickshank, C.; Graham, J.; Hassan, S.; Khoo, V.; Logue, J.; Mayles, H.; Money-Kyrle, J.; Naismith, O.; Panades, M.; Patterson, H.; Scrase, C.; Staffurth, J.; Tremlett, J.; Griffin, C.; Hall, E. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative Analysis of Clinical Outcomes and Procedural Costs between the Conventional Two-stage Technique and 4D Brachytherapy for Early Prostate Cancer. Issue 1 (January 2018) Authors: Langley, S.E.M.; Uribe, J.; Uribe-Lewis, S.; Money-Kyrle, J.; Perna, C.; Khaksar, S.; Soares, R.; Laing, R. Journal: Clinical oncology Issue: Volume 30:Issue 1(2018) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The role of oncologists in management decisions for non-metastatic muscle invasive bladder cancer (MIBC). (June 2016) Authors: Larbi, E.; Thippu Jayaprakash, K.; Roodhouse, A.; Khaksar, S.; Wood, K.; Money-Kyrle, J.; Shaffer, R. Journal: Clinical oncology Issue: Volume 28(2016)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗